Skip to content

Itopride

ALIMENTARY TRACT AND METABOLISM

Also known as: ganaton, itopride HCl, itopride hydrochloride, itropride

ATC A03FA07

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Itopride is a drug catalogued in DrugCentral. Recorded indications include Chronic gastritis.

  • Indications: Chronic gastritis.
  • ATC code: A03FA07 (Propulsives).
  • Molecular formula: C20H26N2O4; molecular weight 358.44 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (1)

  • Chronic gastritis

ATC classification

ATC codeTherapeutic hierarchy
A03FA07ALIMENTARY TRACT AND METABOLISM › DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS › PROPULSIVES › Propulsives

Reported adverse-event signals

Strongest FDA FAERS disproportionality signals (log-likelihood ratio). A signal is a statistical association in spontaneous reports, not proof that the drug causes the event.

MedDRA termLLR
Trimethylaminuria199.9
Pseudomembranous colitis109.4
Megacolon106.6
Peritonitis101.0
Dysbiosis99.0
Intestinal perforation79.9
Inhibitory drug interaction63.6
Drug interaction58.3
Clostridium difficile infection56.9
Breath odour54.7
White blood cells urine positive52.0
Urine odour abnormal51.3

Chemical structure

Full physicochemical, ADMET and 3D-structure analysis of Itopride is on its molecule page.

Molecular formulaC20H26N2O4
Molecular weight358.44 g/mol
CAS number122898-67-3
InChIKeyQQQIECGTIMUVDS-UHFFFAOYSA-N
PubChem CID3792
COC1=C(OC)C=C(C=C1)C(=O)NCC1=CC=C(OCCN(C)C)C=C1

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Itopride used for?

DrugCentral lists the following indications for Itopride: Chronic gastritis.

What is the chemical formula of Itopride?

Itopride has the molecular formula C20H26N2O4 and a molecular weight of 358.44 g/mol.

Browse: all drugs starting with I · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

Status—
First approval—
Agency—
Targets0
Indications1
FormulaC20H26N2O4
DrugCentral ID1512
Interactive profile